Aprecap Capsule

Aprecap Capsule

Aprecap Capsule contains aprepitant, an antiemetic medication used to prevent nausea and vomiting associated with chemotherapy and certain surgeries. It works by blocking the action of neurokinin-1 (NK1) receptors in the brain, which are responsible for triggering vomiting.

Uses

• Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV): Effective in both acute and delayed phases.
• Postoperative Nausea and Vomiting (PONV): Helps prevent nausea and vomiting following surgery.

How Aprecap Works

Aprepitant blocks neurokinin-1 (NK1) receptors, which play a key role in inducing nausea and vomiting. By inhibiting these receptors, Aprecap reduces the activity of chemicals in the brain that lead to these symptoms, particularly during chemotherapy.

Common Side Effects

• Fatigue
• Dizziness
• Hiccups
• Diarrhea
• Loss of appetite

Serious Side Effects (Seek Medical Attention)

• Allergic reactions (rash, itching, swelling of the face/tongue)
• Difficulty breathing
• Severe skin reactions (rare)

Key Features

• Contains aprepitant, a selective NK1 receptor antagonist.
• Effective for preventing both acute and delayed nausea/vomiting from chemotherapy.
• Can be used alongside other antiemetics for comprehensive prevention.

Frequently Asked Questions (FAQ)

1. Can Aprecap be taken with other antiemetic medications? Yes, it is often used with corticosteroids and serotonin antagonists to maximize antiemetic protection.
2. Is Aprecap safe during pregnancy? Consult with your healthcare provider before use during pregnancy, as the safety of aprepitant has not been fully established in pregnant women.
3. How should Aprecap be taken? Follow your doctor’s instructions precisely, typically starting before chemotherapy and continuing as directed.

References

1. National Comprehensive Cancer Network (NCCN) Guidelines for Antiemesis Available from: https://www.ncbi.nlm.nih.gov/books/NBK551588
2. Aprepitant Product Information - FDA Available from: https://go.drugbank.com/drugs/DB00673